+ All Categories
Home > Documents > by 1 April for Early Bird Pricing -...

by 1 April for Early Bird Pricing -...

Date post: 25-May-2018
Category:
Upload: duongkhanh
View: 213 times
Download: 0 times
Share this document with a friend
6
To Register Call +1-212-400-6240 Or visit: www.exlpharma.com/europr ABBOTT AMGEN GMBH BIOGEN IDEC BOEHRINGER INGELHEIM GENZYME GILEAD SCIENCES JANSSEN UK MERCK SERONO NEOPHARM GROUP NOVARTIS PFIZER ROCHE SHIRE UCB PHARMA 3 rd EUROPEAN PUBLIC RELATIONS AND COMMUNICATIONS SUMMIT CHANGE MANAGEMENT CASE STUDY: CULTURE CHANGE Adjusting to New Developments by Creating and Fostering a Culture of Innovation Proudly presents 16-17 May, 2011 The Westin Grand Berlin, Germany Highlighting PR and Communications’ Pivotal Role in Impacting the Critical Issues Facing the Pharmaceutical Industry Featuring Presentations from Leading Pharmaceutical Companies: Why You Must Attend: Register by 1 April for Early Bird Pricing Featuring an Outstanding Speaker Faculty from Leading Companies: Caroline De Bie, Associate Director for Corporate Communication, GENZYME Belgium Fiona Olivier, Strategic Business Communications Director, ABBOTT James Read, Public Affairs, International, GILEAD SCIENCES CRISIS COMMUNICATIONS Proactively Developing Relationships with Influencers to Create an Available Network for Damage Control PUBLIC HEALTH STAKEHOLDER CASE STUDY Stakeholder Relations in the Area of HIV Treatment to Create Synergy Between Your Company’s Initiatives and Advocates’ Needs Only multi-day summit focusing on the leadership role of PR in policy initiatives Third year running in Europe – from the producers of the ultra – successful US PR & Communications Summit and Digital Pharma Highlights why PR should have a seat at the table for all major company wide decisions SPONSOR:
Transcript

To Register Call +1-212-400-6240 Or visit: www.exlpharma.com/europr

ABBOTTAMGENGMBHBIOGENIDECBOEHRINGERINGELHEIMGENZYMEGILEADSCIENCESJANSSENUKMERCKSERONONEOPHARMGROUPNOVARTISPFIZERROCHESHIREUCBPHARMA

3rd EuROpEAn puBliC RElATiOnSAnD COMMuniCATiOnS SuMMiT

CHANGE MANAGEMENT CASE STUDY: CULTURE CHANGEAdjusting to new Developments by Creating and Fostering a Culture of innovation

Proudly presents

16-17 May, 2011 The Westin Grand • Berlin, Germany

Highlighting pR and Communications’ pivotal Role in impacting the Critical issues Facing the pharmaceutical industry

Featuring presentations from leading pharmaceutical Companies:

Why You Must Attend:

Register by 1 April for Early Bird Pricing

Featuring an Outstanding Speaker Faculty from leading Companies:

Caroline De Bie, Associate Director for Corporate Communication, GENZYMEBelgium

Fiona Olivier, Strategic Business Communications Director, ABBOTT

James Read, Public Affairs, International, GILEADSCIENCES

CRISIS COMMUNICATIONSproactively Developing Relationships with influencers to Create an Available network for Damage Control

PUBLIC HEALTH STAKEHOLDER CASE STUDYStakeholder Relations in the Area of HiV Treatment to Create Synergy Between Your Company’s initiatives and Advocates’ needs

Only multi-day summit focusing on the leadership role of pR in policy initiatives• Third year running in Europe – from the producers of the ultra – successful uS pR • & Communications Summit and Digital pharmaHighlights why pR should have a seat at the table for all major company wide decisions•

SpOnSOR:

To Register Call +1-212-400-6240 or visit www.exlpharma.com/europr

Dear Colleague,It is with great pleasure that I announce ExL Pharma’s 3rd Annual European Public Relations & Communications Summit – Eu-rope’s only event where communications professionals from the world’s leading pharmaceutical, biotech, and medical device companies gather to share insights and case studies on the critical issues facing their busi-nesses.

Now, more than ever, Communications Department heads should have a seat at the table for company policy discussions. Changes within pharma-ceutical companies and the industry itself are creating new opportunities for public relations and communications managers to demonstrate their department’s value in the strategy making process and secure a seat at the table. Effective communications are essential for making a difference in areas as diverse as crisis communications, policy initiatives, change management, social media, and market access.

The 3rd Annual European Public Relations & Communica-tions Summit not only features an agenda that covers the most critical issues you need for success in the 2011 and 2012, but also provides an unmatched networking opportunity with the most influential commu-nications professionals in the pharmaceutical, biotech, and medical device industries. I look forward to seeing you in May!

Sincerely,

Dave HoffmanConference [email protected]

Replenish your spirit at The Westin Grand, Berlin – a place where you can be at your best. Upon arrival in our sweeping lobby, we welcome you with sights, sounds, and scents to stir your soul and elevate your senses. After an invigorating workout in our state-of-the-art gym, enjoy a refreshing dip in our pool, followed by some time in our sauna. Exciting and alive, Berlin is a city of contrasts, and a mixture of vitality, culture, commerce, politics, attractions, and history. Our serene and elegant hotel is located right in the centre of all of this, where the historic boulevard Unter den Linden meets the Friedrichstrasse.

Room ReservationsIf you require overnight accommodations, please contact the Westin Grand Berlin at +49 (0) 30 2027 3492 to book your room. ExL has reserved a block of rooms at a discounted rate for conference participants. Please mention ExL Pharma and the conference name to take advantage of the discount. You must book your room by 26 April, 2011 to be eligible for the discounted rate. Please book your room early, as the rooms available at this rate are limited.

Do you want to spread the word about your organization’s solutions and services to potential clients who will be attending this event? Take advantage of the opportunity to sponsor, underwrite an educational session, host a networking event, or distribute promotional items to attendees. ExL Pharma will work closely with you to customize a package that suits all your needs. To learn more about these opportunities, please contact Jayson Mercado at +1 (212) 400-6236, or [email protected].

Who Should Attend? From Pharmaceutical, Biotech, and Medical Device Companies:

• CorporateCommunications• PublicRelations• MediaRelations• Policy• PublicAffairs• GovernmentAffairs• EmployeeCommunications• Product/BrandManagement• Advocacy• Promotions• CommunityRelations• InvestorRelations

You will also meet representativesfrom:

• PRAgenciesandFirms• Consultants• MarketingServiceProviders• PRandSMMeasurementand

EvaluationCompanies• IRAgencies• Associations/Consortiums• CommunityServiceOrganizations• AdvertisingAgenciesBryon Main

Managing DirectorExL Pharma

Dave Hoffman

The Westin Grand BerlinFriedrichstrasse 158-164, 10117 Berlin, Germany | tel +49 (0) 30 2027 3492 fax: +49 (0) 30 2027 3479

Sponsorship and Exhibiting Opportunities

To Register Call +1-212-400-6240 or visit www.exlpharma.com/europr

8:00 RegistrationandContinentalBreakfastforAttendees

9:00 WelcomeandChairperson’sOpeningRemarks

Conference Chair:James Read, Public Affairs, International, GILEADSCIENCES

EXECUTIVEPANEL:THEDYNAMICROLEOFCOMMUNICATIONS9:15 HowTransitionsinthePharmaceuticalandHealthcareIndustries

areIncreasingtheImportanceofaStrongCommunicationsTeam• Making sure PR gets a seat at the table during internal policy

discussions

• Communications’ role in internal change management

• Using all available tools to develop a proactive reputation manage-ment plan for your brand and company

• Understanding and influencing all the key stakeholders in the healthcare marketplace

Moderator:Thomas Bols, Vice President of Corporate Health Policy and Market, MERCKSERONO

Panelists:Steffen Fritzsche, Director, Corporate Communications, UCBPHARMAJessica Mann, Senior Vice President of Global Corporate Communications,SHIRESabine Kostevc, Head of Corporate Internet and Social Media, ROCHE

CHANGEMANAGEMENTCASESTUDY:CULTURECHANGE10:00 AdjustingtoNewDevelopmentsbyCreatingandFosteringa

CultureofInnovation• Understanding pharmaceutical industry shifts and the implications

for communications

• Using innovative communications including video, storytelling, and collaborative online spaces (internal social media) to engage em-ployees and facilitate culture change

Fiona Olivier, Strategic Business Communications Director,ABBOTT

10:45 RefreshmentandNetworkingBreak

CHANGEMANAGEMENTPANEL:MERGERSANDACQUISITIONS11:15 IntegratingCorporateandNationalCulturesinInternational

MergersandAcquisitionstoEnsureSmoothOperationsinLightofCorporateModifications• Training management to communicate with new employees

• Mobilizing employees to adopt new procedures and attitudes

• Examples of specific successful communication measures

Panelists:Sybille Genersch, Head of Communications & Corporate Identity, BOEHRINGERINGELHEIMMartin Fensch, Director Communications Germany and Head Media Relations Oncology Europe,PFIZER

CRISISCOMMUNICATIONS12:00 ProactivelyDevelopingRelationshipswithInfluencerstoCreate

anAvailableNetworkforDamageControl• Cultivating influencer relationships during good times

• Identifying influencers within various stakeholders: patient groups, regulatory authorities and physicians

Caroline De Bie, Associate Director for Corporate Communications, GENZYME

12:45 LuncheonforConferenceParticipants

PANELDISCUSSION:CONNECTINGWITHPOLICYMAKERS1:45 AdoptingaPublicRelationsApproachintotheProcessof

EngagingwithPolicyMakers• Recognizing that public policy increasingly shapes your business

environment at all levels, making policy makers an essential audience

• Treating policymakers as a distinct audience to ensure that your message is tuned to addressing their needs

• Expressing the impact of your treatment in relevant policy terms such as innovation, competitiveness, employment, and solidarity

• Building alliances and developing messages to help align stakehold-ers to press for desirable policy initiatives

Moderator:Colin Mackay, Director of Communications EFPIA

Panelists:Nick Bosanquet, Professor of Health Policy,IMPERIALCOLLEGEMark Grossien, Global Manager Franchise Communications, NOVARTIS

PARTNERINGWITHEXTERNALORGANIZATIONS2:30 ForgingAllianceswithStakeholderGroupstoInfluence

PublicOpinion• Determining your long term partnership objectives when working

with patient advocacy groups

• Understanding the needs and wants of stakeholder organizations to find common ground

• Recognizing when working together as an industry can benefit everyone by growing the marketplace

Maximilian von Olenhusen, Director Public Affairs,NOVARTIS

3:15 RefreshmentandNetworkingBreak

PUBLICHEALTHSTAKEHOLDERCASESTUDY3:45 StakeholderRelationsintheAreaofHIVTreatmenttoCreate

SynergyBetweenYourCompany’sInitiativesandAdvocates’Needs• Responding to public opinion regarding research, access to medi-

cine, and commercial operations• Listening to the goals of patient advocates and activists• Involving external stakeholders in determining changes in how trials

are done and how drugs are provided

• Listening to external stakeholders in determining R&D directions

James Read, Public Affairs, International, GILEADSCIENCES

Conference Day One: Monday, 16 May, 2011

To Register Call +1-212-400-6240 or visit www.exlpharma.com/europr

CORPORATESOCIALRESPONSIBILITY4:30 HowPublicRelationsInformCorporateSocialResponsibilityEffortsasCorporateBrandingInitiatives

• How do you select a CSR cause that is congruent with your company’s goals?

• What are the key issues in selecting and working with partners for CSR projects?

• Making sure that your CSR story gets told

• Creating an integrated methodology for how CSR is part of a corporate, product, internal, and web communications function as it affects branding and reputation

Jan Willem de Heer, Communications Manager, Public Affairs and Policy, PFIZER

5:15 EndofDayOne

9:00 Chairperson’sRecapConference Chair:James Read, Public Affairs, International, GILEADSCIENCES

BECOMINGANEWSSOURCEOFCHOICEIN2011/20129:15 PositioningYourselfasaTrustedResourceforJournalists

CoveringtheHealthcareandPharmaceuticalIndustrytoAddValuetoYourCompany’sStrategicOperations• How will your company fit in with what journalists see as the hot

stories affecting the pharmaceutical industry in for the rest of the year?

• Why developing the kind of expertise to become a resource to reporters can also increase your influence within your company

• Challenges that are facing journalists covering the healthcare and pharmaceutical industries

• What kinds of pharmaceutical and health related stories are under-reported and what opportunities are there for coverage?

• Providing access with the most relevant and useful sources

Panelists:Uri Goren, Spokesperson and PR Manager,NEOPHARMGROUPMelanie Senior, Bureau Chief, Europe, ELSEVIERBUSINESSINTELLIGENCE,THEPINKSHEETMatt Thomson, Managing Director, Europe, SYNAPTICDIGITALAndrew Widger, Director of Media Relations, Europe, Middle East, and Africa, PFIZER

MARKETACCESS10:00 WhatistheExtentoftheCommunicationsDepartment’sRole

inMarketAccess?• Preparing stakeholders by effectively communicating data to illus-

trate that the drug does what is promised

• Communicating advantages of a drug to support favorable pricing and reimbursement guidelines

• Shifting the conversation away from cost and price and refocusing on the value of drugs

Helen Mills, Director, External Communications, AMGENGMBH

10:30 RefreshmentandNetworkingBreak

CASESTUDY:DESIGNINGACOMMUNICATIONSDEPARTMENT11:00 ALookatHowUCBRespondedtoIndustryChangesby

EmpoweringtheCommunicationsFunctionwiththeCreation ofaDedicatedCommunicationsDepartment• Merging with Schwarz Pharma spurred UCB to form a dedicated

communications department• Choosing members to form a team to develop a strategy for media

and internal communications• Designing a strategy to coordinate communications for a restruc-

turing international company

• Lessons learned in structuring a communications department

Steffen Fritzsche, Director, Corporate Communications, UCBPHARMA

SOCIALMEDIASTRATEGY11:45 UsingSocialMediatoInfluencetheExchangeofIdeasandInfor-

mationRegardingTreatmentOptionsandYourCorporateBrand• Recognizing that online, new media conversations happen among

stakeholders whether your company is involved or not• Examining how a corporate social media strategy fits into the exist-

ing external dialog• Providing dynamic, frequently updated, relevant information through

social media outlets• Establishing benchmarks for proactively using social media to influ-

ence the public directly

Alex Butler, Director Strategy & Social Media Manager,JANSSEN

12:30 NetworkingLuncheon

PFIZERCASESTUDY:PRANDSOCIALMEDIA1:30 CoordinatingtheSocialMediaEffortsandInterestsofthe

Marketing,PR,MedicalandOtherDepartmentstoAvoidConfusingthePublic• Coming to an agreement over who’s doing what with social media outlets

• Developing guidelines for Facebook, Twitter and blogs

• Creating an authority and/or governance models regarding social media

• How to handle bloggers who spread negative or inaccurate infor-mation about your drug

Andrew Widger, Director of Media Relations, Europe, Middle East, and Africa, PFIZER

Conference Day Two: Tuesday, 17 May, 2011

To Register Call +1-212-400-6240 or visit www.exlpharma.com/europr

SOCIALMEDIACASESTUDY:FACEBOOKASAPHARMAPRTOOL

2:15 DevelopingaSeriesofFacebookPagesasaPublicRelationsTooltoInfluenceSpecificAudiences• Will Facebook move journalists out of the information value chain?

• Diversifying Facebook pages to interact with different audiences: as a lobbying tool, to influence doctors, to educate the industry, or to engage journalists

• Creating a Facebook app game to recruit newsfeed followers

John Pugh, Head of Online Communications, BOEHRINGERINGELHEIM

LEADERSHIPCOMMUNICATIONS3:00 MobilizingEmployeesasAmbassadorsforYourCorporateBrand

• Providing vision and direction, and reminding people of your com-pany’s purpose

• Setting the right example for communicating positively about your activities

• Offering tools and guidelines for employees to talk about your business

• Letting employees own and feel like a part of the company story

Katja Buller, Senior Director, Public Affairs International, BIOGENIDEC

Media Partners

GroupDiscountProgram:

Save 25% per person when Registering Four For every three simultaneous registra-tions from your company, you will re-ceive a fourth complimentary registra-tion to the program (must register 4 at one time). This is a savings of 25% per person.

Save 15% per person when Registering Three Can only send three? You can still save 15% off of every registration. To find out more on how you can take advan-tage of these group discounts, please call +1 212-400-6240.

Make checks payable to ExL Events, Inc. and write code P911 on your check.You may also use Visa, MasterCard, Dis-cover or American Express. Payments must be received in full prior to the commencement of the conference.

RegistrationFeesforAttendingExLPharma’s 3rd Annual European Public Relations & Communications Summit:

EARLY BIRD PRICINGRegister by Friday, 1 April, 2011 to Take Advantage of Early-Bird Pricing:

Conference Only €1495

STANDARD PRICING

Register After Friday, 1 April, 2011:

Conference Only €1795

FourWaystoRegister

Mail: ExL Events, Inc. 555 8th Ave, Ste 310 New York, NY 10018

Phone: +1-212-400-6240

Email: [email protected]

Online: www.exlpharma.com/europr

PleaseNote: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, every effort to find a suitable replacement will be made.

* The opinions of this faculty do not necessarily reflect those of the companies they represent or ExL Events, Inc. *

Do you have a question about the event? Would you like to get involved as a speaker or discussion leader at our 4th European Public Relations and Communications Summit? Please email Conference Director, Dave Hoffman at [email protected]

3:45 ConferenceConcludes

Cancellations:

If you need to cancel your registration for an upcoming ExL conference, please note the fol-lowing policies derived from the Start Date of the event:

Four weeks or more: A full refund (minus a €95 processing fee), or a voucher to another ExL event valid for two years from the voucher issue date.

Four weeks or less: A voucher to another ExL event valid for two years from the voucher is-sue date.

To receive a refund or voucher, please fax your request to +1 212-400-6240.

Please note: Conference registrations may be transferred to other colleagues in the event you are unable to attend. There will be an adminis-trative charge of €300 to substitute, exchange and/or replace attendance badges with a col-league occurring within five business days of any ExL conference.

Please notify ExL Pharma, [email protected], prior to the event with the name and contact information of the replacement attendee.

To Register Call +1 212-400-6240 Or visit: www.exlpharma.com/europr

Why You Must Attend:

3rd EuROpEAn puBliC RElATiOnS

AnD COMMuniCATiOnS SuMMiT

Proudly presents

16-17 May, 2011 The Westin Grand • Berlin, Germany

Highlighting pR and Communications’ pivotal Role in impacting the Critical issues Facing the pharmaceutical industry

Register by 1 April for Early Bird Pricing

Only multi-day summit focusing on the leadership role of pR in policy initiatives • Third year running in Europe – from the producers of the ultra – successful uS pR • & Communications Summit and Digital pharmaHighlights why pR should have a seat at the table for all major company wide decisions •

ABBOTT

AMGENGMBH

BIOGENIDEC

BOEHRINGERINGELHEIM

GENZYME

GILEADSCIENCES

JANSSENUK

MERCKSERONO

NEOPHARMGROUP

NOVARTIS

PFIZER

SHIRE

UCBPHARMA

Featuring an Outstanding Speaker Faculty from leading Companies:

SpOnSOR:

To Register:+1 212-400-6240

www.exlpharma.com/europr

q Yes! Register me for the Conference

Please contact me:

q I’m interested in marketing opportunities at this event

q I wish to receive email updates on Exl Pharma’s upcoming events

Name:

Title:

Company:

Dept.:

Address:

City:

State: Zip:

Email:

Telephone:

Fax:

METHOD OF PAYMENT: q Check q Credit Card

Make checks payable to ExL Events, Inc.

CARD TYPE: q MasterCard q Visa q Discover q Amex

Card Number:

Exp. Date:

Name on Card:

Signature:


Recommended